Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Oncotarget|October 6, 2017
Long non-coding RNAs associated with non-small cell lung cancerYuting Zhan, Hongjing Zang, Juan Feng, et al.Frontiers in Oncology|March 24, 2022
Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric AdenocarcinomaChun-Hong Hu, Shenghao Shi, Wen Dong, et al.Frontiers in Immunology|May 2, 2025
CD19+ B cell depletion: a novel strategy to alleviate ischemic stroke damageYu Xu, Jing Peng, Yizhong Yan, et al.Cancer|December 11, 2019
ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinibYiting Li, Hongjing Zang, Guoqing Qian, et al.Scientific Reports|April 6, 2026
RNA-based next-generation sequencing strategy for screening MDM2-amplified sarcomasCheng Lei, Hongjing Zang, Haixia Zhang, et al.Pathology, Research and Practice|June 15, 2026
HSP10, HSP60, and HSP70 overexpression associates with PD-L1 upregulation and adverse outcomes in on-small cell lung cancerYuling Zhang, Ying Zhou, Yang Yang, et al.Cancer Medicine|June 30, 2022
Increased expression of FAT4 suppress metastasis of lung adenocarcinoma through regulating MAPK pathway and associated with immune cells infiltrationYue Ning, Yang Yang, Hongmei Zheng, et al.Cancer Cell International|March 22, 2025
YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathwayHongmei Zheng, Yaoxiang Tang, Hongjing Zang, et al.BMC Oral Health|September 3, 2023
High expression of HSP60 and survivin predicts poor prognosis for oral squamous cell carcinoma patientsYing Zhou, Yaoxiang Tang, Jiadi Luo, et al.Critical Reviews in Oncology/Hematology|November 30, 2023
Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomasSongqing Fan, Hongmei Zheng, Yuting Zhan, et al.Pageof 5